{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:47:53Z","timestamp":1792802873377,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019MH117"],"award-info":[{"award-number":["ZR2019MH117"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Special fund for clinical research of Chinese Medical Association","award":["18010140743"],"award-info":[{"award-number":["18010140743"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.yrtph.2019.104544","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T20:16:37Z","timestamp":1574712997000},"page":"104544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways"],"prefix":"10.1016","volume":"110","author":[{"given":"Ning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huishan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenteng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.104544_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yrtph.2017.12.023","article-title":"A reappraisal on metformin","volume":"92","author":"Adak","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104544_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2016.06.009","article-title":"Berberine as a photosensitizing agent for antitumoral photodynamic therapy: insights into its association to low density lipoproteins","volume":"510","author":"Andreazza","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2019.104544_bib3","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jcb.27102","article-title":"Berberrubine and its analog, hydroxypropyl-berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells","volume":"120","author":"Cao","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yrtph.2019.104544_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1096\/fsb2fj000435fje","article-title":"Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport","volume":"15","author":"Carvalho","year":"2001","journal-title":"FASEB J. : Off. Publ. Feder. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.yrtph.2019.104544_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu10010051","article-title":"Gelidium elegans extract ameliorates type 2 diabetes via regulation of MAPK and PI3K\/Akt signaling","volume":"10","author":"Choi","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.yrtph.2019.104544_bib6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/s41467-019-09318-3","article-title":"Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling","volume":"10","author":"Choi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yrtph.2019.104544_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.clinbiochem.2012.02.005","article-title":"HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes","volume":"45","author":"Coniglio","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.yrtph.2019.104544_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yrtph.2019.104544_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cen.13931","article-title":"Adipocyte expression of glucose transporter 1 and 4 in PCOS: relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake","volume":"90","author":"Ezeh","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.yrtph.2019.104544_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.lfs.2009.07.003","article-title":"Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus","volume":"85","author":"Hanai","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2019.104544_bib11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.12691\/jfnr-3-10-5","article-title":"Dieckol improve insulin sensitivity through the regulation of the PI3K pathway in C57BL\/KsJ-db\/db mice","volume":"3","author":"Jeon","year":"2015","journal-title":"J. Food Nutr. Res."},{"key":"10.1016\/j.yrtph.2019.104544_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/13880209.2018.1548627","article-title":"Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2\/ERK pathway","volume":"56","author":"Jin","year":"2018","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yrtph.2019.104544_bib13","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2019.104544_bib14","first-page":"656","article-title":"A new insulin-sensitivity index for the population-based study","volume":"32","author":"Li","year":"1993","journal-title":"Zhonghua nei ke za zhi"},{"key":"10.1016\/j.yrtph.2019.104544_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1745-6215-14-226","article-title":"Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial","volume":"14","author":"Li","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.yrtph.2019.104544_bib16","doi-asserted-by":"crossref","first-page":"e0144072","DOI":"10.1371\/journal.pone.0144072","article-title":"A single arm pilot study of effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yrtph.2019.104544_bib17","first-page":"574","article-title":"Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.yrtph.2019.104544_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1933719116667606","article-title":"Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome","volume":"24","author":"Li","year":"2017","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.yrtph.2019.104544_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2532935","article-title":"The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review","author":"Li","year":"2018","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.yrtph.2019.104544_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lfs.2019.04.064","article-title":"Berberine ameliorates oxidative stress-induced apoptosis by modulating ER stress and autophagy in human nucleus pulposus cells","volume":"228","author":"Luo","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2019.104544_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09513590.2017.1370644","article-title":"Therapeutic approach for metabolic disorders and infertility in women with PCOS","volume":"34","author":"Morgante","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.yrtph.2019.104544_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2019.01.048","article-title":"Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome","volume":"220","author":"Moulana","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2019.104544_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","article-title":"Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies","volume":"243","author":"Pirillo","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.yrtph.2019.104544_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/13880209.2016.1258425","article-title":"Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism","volume":"55","author":"Rajan","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yrtph.2019.104544_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/13880209.2015.1091482","article-title":"Phosphatidylinositide 3-kinase inhibition: a new potential target for the treatment of polycystic ovarian syndrome","volume":"54","author":"Shah","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yrtph.2019.104544_bib26","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2337\/diabetes.50.8.1901","article-title":"Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt\/protein kinase B and atypical protein kinase C (zeta\/lambda) activities","volume":"50","author":"Tremblay","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.yrtph.2019.104544_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2015.10.028","article-title":"Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives","volume":"176","author":"Wang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yrtph.2019.104544_bib28","first-page":"3866","article-title":"Systematic Evaluation of the randomized controlled trial system for polycystic ovary syndrome treated by berberine and metformin","volume":"36","author":"Wang","year":"2015","journal-title":"Guangdong Med. J."},{"key":"10.1016\/j.yrtph.2019.104544_bib29","doi-asserted-by":"crossref","first-page":"28089","DOI":"10.1038\/srep28089","article-title":"Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2019.104544_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/1933719116667218","article-title":"Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment","volume":"24","author":"Wang","year":"2017","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.yrtph.2019.104544_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2018.01.034","article-title":"Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGF beta 1-PI3K\/AKT pathway","volume":"824","author":"Wang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104544_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jep.2018.04.025","article-title":"Achyranthis bidentatae radix enhanced articular distribution and anti-inflammatory effect of berberine in Sanmiao Wan using an acute gouty arthritis rat model","volume":"221","author":"Wu","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.yrtph.2019.104544_bib33","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1152\/ajpendo.00211.2007","article-title":"Berberine improves glucose metabolism through induction of glycolysis","volume":"294","author":"Yin","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.yrtph.2019.104544_bib34","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/00029330-200811010-00003","article-title":"Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus","volume":"121","author":"Zhang","year":"2008","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.yrtph.2019.104544_bib35","first-page":"1","article-title":"Berberine moderates glucose and lipid metabolism through multipathway mechanism","author":"Zhang","year":"2011","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.yrtph.2019.104544_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.fertnstert.2010.07.1090","article-title":"Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro","volume":"95","author":"Zhao","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.yrtph.2019.104544_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40199-017-0188-7","article-title":"Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K\/AKT pathway","volume":"25","author":"Zhao","year":"2017","journal-title":"Daru"},{"key":"10.1016\/j.yrtph.2019.104544_bib38","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1159\/000445565","article-title":"Regulation of insulin resistance by multiple MiRNAs via targeting the GLUT4 signalling pathway","volume":"38","author":"Zhou","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yrtph.2019.104544_bib39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11596-018-1953-7","article-title":"MIF may participate in pathogenesis of polycystic ovary syndrome in rats through MAPK signalling pathway","volume":"38","author":"Zhou","year":"2018","journal-title":"Curr. Med. Sci."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:29:01Z","timestamp":1759494541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019303083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":39,"alternative-id":["S0273230019303083"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104544"}}